Pieczonka, C. M., Ly, C., Moradian, H., Reiher, J., Flanders, S. C., Huang, M., Brown, B., Reddy, S. B., Edwards, B. B. (2026). A matched-adjusted indirect comparison (MAIC) of nogapendekin alfa inbakicept-pmln plus bacillus Calmette–Guérin (NAI+BCG) and pembrolizumab in patients with BCG-unresponsive non–muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) ± papillary disease.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16619